The blockade of interleukin-6 receptor as a therapeutic strategy for chronic inflammatory diseases

Author： Hoshino-Yoshio Naoko   Watanabe Dai   Adachi Yasuo   Nishimoto Norihiro  

Publisher： Future Medicine

ISSN： 1475-0708

Source： Therapy, Vol.1, Iss.2, 2004-11, pp. : 267-275

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-Interleukin-6 Receptor Antibody Treatment in Inflammatory Autoimmune Diseases

By  

Reviews on Recent Clinical Trials, Vol. 1, Iss. 3, 2006-09 ,pp. : 193-200

Bentham Science Publishers

Access to resources Recommend Favorite

Tocilizumab: A novel humanized anti-interleukin 6 (IL-6) receptor antibody for the treatment of patients with non-RA systemic, inflammatory rheumatic diseases

By Alten Rieke   Maleitzke Tazio  

Annals of Medicine, Vol. 45, Iss. 4, 2013-06 ,pp. : 357-363

Informa Healthcare

Access to resources Recommend Favorite

Interleukin-6 and interleukin-6 receptor secretion by chronic lymphatic leukaemia and normal B lymphocytes: effect of PMA and PWM

By Drucker I.   Klajman A.   Revel Ca M.   Manor Y.   Ben-Efraim S.   Novick D.  

Mediators of Inflammation, Vol. 6, Iss. 2, 1997-04 ,pp. : 147-153

Informa Healthcare

Access to resources Recommend Favorite

Blockade of interleukin‐6 receptor enhances the anti‐arthritic effect of glucocorticoids without decreasing bone mineral density in mice with collagen‐induced arthritis

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 182, Iss. 2, 2015-11 ,pp. : 154-161

John Wiley & Sons Inc

Access to resources Recommend Favorite

The effects of chronic exercise on the inflammatory cytokines interleukin-6 and tumor necrosis factor-α are different with age

By Moon Min Kyong  

Applied Physiology, Nutrition, and Metabolism, Vol. 37, Iss. 4, 2012-08 ,pp. : 631-636

NRC Research Press

Access to resources Recommend Favorite